Indigestion — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for indigestion. 15 active patents protecting 2 drugs from 2+ originators. First major cliff: 2026. Daily refresh.

2
Approved drugs
15
Active US patents
65/100
Avg vulnerability
—
Annual revenue covered

Originators in Indigestion

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Baxter 10 patents Generic (originally Yamanouchi/Merck) 5 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating indigestion. Each bar = one year. Y-axis scaled to peak year (5 patents).

5
26
2
28
4
33
3
34
1
38

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Renacidin
CITRIC ACID
 Baxter 10 56 — 2028-10-10
Pepcid
famotidine
 Generic (originally Yamanouchi/Merck) 5 73 — 2026-07-18

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
8067451 Pepcid method of use 85 2026-07-18
8501228 Pepcid method of use 85 2026-07-18
11992472 Renacidin method of use 75 2033-03-15
11337989 Renacidin method of use 70 2033-03-15
8309127 Pepcid formulation 65 2026-07-18
8449910 Pepcid formulation 65 2026-07-18
8318202 Pepcid formulation 65 2026-07-18
10568855 Renacidin method of use 62 2033-03-15
11191753 Renacidin method of use 62 2034-06-23
9827231 Renacidin method of use 62 2034-06-26

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
11439610 Renacidin composition of matter 12 2033-03-15
10624879 Renacidin formulation 42 2034-06-23
12458634 Renacidin formulation 55 2038-01-27
8481083 Renacidin formulation 60 2028-10-10
8450338 Renacidin formulation 60 2028-10-10
9827231 Renacidin method of use 62 2034-06-26
11191753 Renacidin method of use 62 2034-06-23
10568855 Renacidin method of use 62 2033-03-15
8318202 Pepcid formulation 65 2026-07-18
8449910 Pepcid formulation 65 2026-07-18

Related